These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 10212891)

  • 41. Antimalarial Effect of 3-Methoxy-1,2-Dioxetanes on the Erythrocytic Cycle of Plasmodium falciparum.
    Lopes NS; Yoshitake AM; Silva AF; Oliveira VX; Silva LS; Pinheiro AA; Ciscato LF
    Chem Biol Drug Des; 2015 Dec; 86(6):1373-7. PubMed ID: 26032859
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular Mechanisms of Drug Resistance in
    Wicht KJ; Mok S; Fidock DA
    Annu Rev Microbiol; 2020 Sep; 74():431-454. PubMed ID: 32905757
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Combination therapy as a strategy to prevent antimalarial drug resistance].
    Orjuela P; González I; Osorio L
    Biomedica; 2004 Dec; 24(4):423-37. PubMed ID: 15678806
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of artemisinin combined with standard antimalarials against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro.
    Chawira AN; Warhurst DC
    J Trop Med Hyg; 1987 Feb; 90(1):1-8. PubMed ID: 3546715
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs.
    Skinner TS; Manning LS; Johnston WA; Davis TM
    Int J Parasitol; 1996 May; 26(5):519-25. PubMed ID: 8818732
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Why artemisinin and certain synthetic peroxides are potent antimalarials. Implications for the mode of action.
    Jefford CW
    Curr Med Chem; 2001 Dec; 8(15):1803-26. PubMed ID: 11772352
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum.
    Barnes KI; White NJ
    Acta Trop; 2005 Jun; 94(3):230-40. PubMed ID: 15878154
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine, and mefloquine.
    Alin MH; Kihamia CM; Bjorkman A; Bwijo BA; Premji Z; Mtey GJ; Ashton M
    Am J Trop Med Hyg; 1995 Dec; 53(6):639-45. PubMed ID: 8561267
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dihydroartemisinin-Ferriprotoporphyrin IX Adduct Abundance in Plasmodium falciparum Malarial Parasites and the Relationship to Emerging Artemisinin Resistance.
    Heller LE; Goggins E; Roepe PD
    Biochemistry; 2018 Dec; 57(51):6935-6945. PubMed ID: 30512926
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structure-activity relationships of the antimalarial agent artemisinin. 8. design, synthesis, and CoMFA studies toward the development of artemisinin-based drugs against leishmaniasis and malaria.
    Avery MA; Muraleedharan KM; Desai PV; Bandyopadhyaya AK; Furtado MM; Tekwani BL
    J Med Chem; 2003 Sep; 46(20):4244-58. PubMed ID: 13678403
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of beta-artemether and beta-arteether against malaria parasites in vitro and in vivo.
    Shmuklarsky MJ; Klayman DL; Milhous WK; Kyle DE; Rossan RN; Ager AL; Tang DB; Heiffer MH; Canfield CJ; Schuster BG
    Am J Trop Med Hyg; 1993 Mar; 48(3):377-84. PubMed ID: 8470775
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of artemisinin derivatives for the control of malaria.
    Nosten F; Hien TT; White NJ
    Med Trop (Mars); 1998; 58(3 Suppl):45-9. PubMed ID: 10212897
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanism-based design of parasite-targeted artemisinin derivatives: synthesis and antimalarial activity of new diamine containing analogues.
    Hindley S; Ward SA; Storr RC; Searle NL; Bray PG; Park BK; Davies J; O'Neill PM
    J Med Chem; 2002 Feb; 45(5):1052-63. PubMed ID: 11855985
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem).
    Sisowath C; Strömberg J; Mårtensson A; Msellem M; Obondo C; Björkman A; Gil JP
    J Infect Dis; 2005 Mar; 191(6):1014-7. PubMed ID: 15717281
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Artemisinin and its derivatives: an important new class of antimalarial agents.
    Balint GA
    Pharmacol Ther; 2001; 90(2-3):261-5. PubMed ID: 11578659
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The threat of artemisinin resistant malaria in Southeast Asia.
    Hanboonkunupakarn B; White NJ
    Travel Med Infect Dis; 2016; 14(6):548-550. PubMed ID: 27915001
    [No Abstract]   [Full Text] [Related]  

  • 57. Potentiation of artemisinin activity against chloroquine-resistant Plasmodium falciparum strains by using heme models.
    Benoit-Vical F; Robert A; Meunier B
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2555-8. PubMed ID: 10508044
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antidogmatic approaches to artemisinin resistance: reappraisal as treatment failure with artemisinin combination therapy.
    Krishna S; Kremsner PG
    Trends Parasitol; 2013 Jul; 29(7):313-7. PubMed ID: 23623760
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rational use of drugs against Plasmodium falciparum.
    Warhurst DC; Duraisingh MT
    Trans R Soc Trop Med Hyg; 2001; 95(4):345-6. PubMed ID: 11579870
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanism of antimalarial action of the synthetic trioxolane RBX11160 (OZ277).
    Uhlemann AC; Wittlin S; Matile H; Bustamante LY; Krishna S
    Antimicrob Agents Chemother; 2007 Feb; 51(2):667-72. PubMed ID: 17145800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.